Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

Isodiol International Inc.

Isodiol International Inc. offers CBD products.

	Mar '19
asset turnover	0.94 -
cash conversion cycle	166.37 -
cash per share	0.06 -
company equity multiplier	3.41 -
days of inventory outstanding	11.33 -
days of payables outstanding	73.05 -
days of sales outstanding	228.08 -
dividend yield
ebit per revenue	-1.76 -
ebt per ebit	3.10 -
effective tax rate	0.00 -
enterprise value multiple	-1.86 -
fixed asset turnover	13.76 -
free cash flow per share	-0.56 -
gross profit margin	-0.24 -
interest coverage	-6.54 -
inventory turnover	32.22 -
long term debt to capitalization	0.43 -
net income per ebt	1.00 -
net profit margin	-5.42 -
operating cash flow per share	-0.47 -
operating cycle	239.41 -
operating profit margin	-1.76 -
payables turnover	5.00 -
pretax profit margin	-5.43 -
price fair value	8.81 -
receivables turnover	1.60 -
return on assets	-5.11 -
return on capital employed	-3.22 -
return on equity	-17.40 -
total debt to capitalization	0.54 -

ISOL

COM:ISODIOL

Isodiol International Inc.

Market Cap

135.44K

Beta: -

Volume Today

500

Avg: -

Preview